Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net income attributable to common shareholders	$ 4,810,149	$ 1,168,025
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	94,608	(457,864)
Realized investment gains, net	(9,117,125)	(7,411,658)
Unrealized trading (gains) losses included in income	111,531	(31,259)
Realized trading (gains) losses included in income	(110,470)	0
Amortization of cost of insurance acquired	839,105	872,982
Depreciation	701,809	698,374
Net income attributable to noncontrolling interest	2,983	288,260
Charges for mortality and administration of universal life and annuity products	(6,636,270)	(5,588,667)
Interest credited to account balances	4,346,943	4,539,416
Change in accrued investment income	(117,871)	(51,512)
Change in reinsurance receivables	556,891	89,524
Change in policy liabilities and accruals	(2,794,247)	(4,679,857)
Change in income taxes receivable (payable)	673,831	(604,639)
Change in other assets and liabilities, net	(6,560,115)	(207,312)
Net cash used in operating activities	(13,198,248)	(11,376,187)
Proceeds from investments sold and matured:
Fixed maturities available for sale	29,744,619	30,355,159
Equity securities available for sale	7,479,886	13,785,226
Trading securities	0	72,279
Mortgage loans	1,840,610	7,047,158
Real estate	13,014,387	11,142,322
Notes receivable	2,170,322	4,463,966
Policy loans	1,951,222	723,317
Short-term investments	0	0
Total proceeds from investments sold and matured	56,201,046	67,589,427
Cost of investments acquired:
Fixed maturities available for sale	(15,615,699)	(11,404,577)
Equity securities available for sale	(3,275,532)	(5,262,588)
Trading securities	0	(70,690)
Mortgage loans	(360,531)	(6,935,273)
Real estate	(4,226,106)	(15,935,233)
Notes receivable	(4,297,853)	(11,208,299)
Policy loans	(1,440,230)	(109,207)
Short-term investments	0	0
Total cost of investments acquired	(29,215,951)	(50,925,867)
Purchase of property and equipment	0	0
Net cash provided by investing activities	26,985,095	16,663,560
Cash flows from financing activities:
Policyholder contract deposits	4,812,703	5,087,358
Policyholder contract withdrawals	(4,139,797)	(4,261,609)
Proceeds from notes payable/line of credit	0	2,900,000
Payments of principal on notes payable/line of credit	(2,900,000)	0
Purchase of treasury stock	(604,052)	(5,432,194)
Issuance of stock	261,487	307,887
Non controlling contributions (distributions) of consolidated subsidiary	(939,537)	(554,882)
Net cash used in financing activities	(3,509,196)	(1,953,440)
Net increase in cash and cash equivalents	10,277,651	3,333,933
Cash and cash equivalents at beginning of year	15,156,548	11,822,615
Cash and cash equivalents at end of year	$ 25,434,199	$ 15,156,548